BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 1,582,450 | $9,890,312 | 26.01% |
| Rosenberg Matthew Hamilton | 12 | $75 | 0.00% |
External links
This page lists BRIACELL THERAPEUTICS CORP's shareholders in Q3 2023. To view BRIACELL THERAPEUTICS CORP's shareholder history, click here.